vimarsana.com

Page 6 - மருந்து கண்காணிப்பு நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Colombia approves J&J Covid-19 vaccine for emergency use

Colombia approves J&J Covid-19 vaccine for emergency use
pharmaceutical-technology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-technology.com Daily Mail and Mail on Sunday newspapers.

Clever Leaves and Ethypharm Announce German Pharmaceutical Cannabis Partnership

Clever Leaves and Ethypharm Announce German Pharmaceutical Cannabis Partnership NEW YORK, March 17, 2021 (GLOBE NEWSWIRE) Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) ( Clever Leaves or the Company ), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced the signing of a supply agreement with Ethypharm ( Ethypharm ), a European manufacturer and distributor of pharmaceutical products, for the sale of medical cannabis extracts produced in Clever Leaves EU-GMP certified facilities in Colombia. The initial portfolio of products includes high-CBD, high-THC, and balanced CBD and THC formulations developed exclusively by Clever Leaves to meet the regulatory needs of the German market.

Timeline: Latin America s Road to Get Vaccinated

Timeline: Latin America s Road to Get Vaccinated
as-coa.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from as-coa.org Daily Mail and Mail on Sunday newspapers.

Clever Leaves Receives Largest 2021 Production Quotas from the Colombian Government Clever Leaves quota represents 50% of the total quota for Colombia and approximately 18% of the world s legal production quota of medical cannabis

NEW YORK, March 02, 2021 (GLOBE NEWSWIRE) Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, today announced that the Colombian Technical Quotas Group (“TQG”) authorized Clever Leaves’ Colombian operations to manufacture up to approximately 59,000 kilograms of cannabis into dried flower derivatives. According to the International Narcotics Control Board’s publicly disclosed data, Clever Leaves’ total allocation represents 50% of Colombia’s total quota and approximately 18% of the world’s legal medical cannabis production quota for 2021. The new 2021 production quota authorizes Clever Leaves to extract medical cannabis and the total quantity allocated to their company is forecasted to be sufficient towards meeting the aggregate international demand for Clever Leaves’ products. To date, Clever Leaves has successfully exported to m

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.